Starpharma Pty Ltd (External organisation)

Description

Modified Macromolecules
US8703116B2 - United States

Abstract: The present invention relates to a macromolecule having a controlled terminal group stoichiometry, the macromolecule including a surface layer, at least one subsurface layer and at least two terminal groups including: a first terminal group which is a residue of a pharmaceutically active agent, a derivative thereof or precursor therefor; and a second terminal group selected to modify the pharmacokinetics of the pharmaceutically active agent and/or macromolecule, wherein terminal group stoichiometry refers to the number and type of terminal groups.

Period	22 Apr 2014
Held at	Starpharma Pty Ltd, Australia, Victoria
Degree of Recognition	National